Current Report Filing (8-k)
September 16 2020 - 04:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Date of Report (Date of earliest event reported): September 16,
2020
Wearable Health Solutions,
Inc.
(Exact name of registrant as specified in its charter)
Nevada |
|
024-11316 |
|
26-3534190 |
(State or Other
Jurisdiction |
|
(Commission File |
|
(I.R.S. Employer |
of
Incorporation) |
|
Number) |
|
Identification Number) |
2300 Yonge Street, Suite 1600
Toronto, ON M4P 1E4 |
(Address of principal executive offices,
including zip code) |
(647) 792-0402 |
(Registrant’s telephone number,
including area code)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which
registered |
N/A |
N/A |
N/A |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
On September 11, 2020, Wearable Health Solutions, Inc. (the
“Company”), filed a Regulation-A prospectus.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of Regulation A, the issuer has
duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
Wearable Health Solutions, Inc.
|
|
|
Date: September 16, 2020 |
By: |
/s/ Harrysen
Mittler |
|
|
Harrysen Mittler, Chief Executive
Officer |